Clinical brain imaging with isopropyl-iodoamphetamine and SPECT

Journal Article · Tue Oct 01 00:00:00 EDT 1985 · Semin. Nucl. Med.; (United States)

DOI:https://doi.org/10.1016/S0001-2998(85)80014-3· OSTI ID:6137559

Royal, H D; Hill, T C; Holman, B L

In recent years, fierce competition has developed between the new high technology specialties of ultrasound, nuclear medicine, computerized transmission tomography, and most recently, nuclear magnetic resonance. Conventional brain scintigraphy, once the most common nuclear medicine procedure, has fallen victim to this rivalry despite the fact that routine scintigraphy remains a good diagnostic test. The agony of this defeat initially caused self-doubt among nuclear medicine physicians, but out of this gloom has emerged a number of radionuclide tests which have the potential to revolutionize how clinical neurology/psychiatry is practiced. 109 references.

• Research Organization: Harvard Medical School, Boston MA
• OSTI ID: 6137559
• Journal Information: Semin. Nucl. Med.; (United States), Vol. 4
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
BRAIN
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
RADIOPHARMACEUTICALS
TISSUE DISTRIBUTION
AMPHETAMINES
EPILEPSY
IODINE ISOTOPES
ANALEPTICS
AUTONOMIC NERVOUS SYSTEM AGENTS
BODY
CENTRAL NERVOUS SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
COMPUTERIZED TOMOGRAPHY
DIAGNOSTIC TECHNIQUES
DISEASES
DISTRIBUTION
DRUGS
EMISSION COMPUTED TOMOGRAPHY
ISOTOPES
LABELLED COMPOUNDS
NERVOUS SYSTEM
NERVOUS SYSTEM DISEASES
ORGANS
SYMPATHOMIMETICS
TOMOGRAPHY
550601* - Medicine- Unsealed Radionuclides in Diagnostics